Growth hormone treatment and bone mineral density in pediatric patients with Prader-Willi syndrome
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Growth hormone treatment and bone mineral density in pediatric patients with Prader-Willi syndrome

Oto Y;Murakami N;Inoue T;Matsubara K;Saima S;Ogata H;Ihara H;Nagai T;Matsubara T;;
journal of pediatric endocrinology & metabolism : jpem 2021 Vol. 34 pp. -
147
y2021journalgrowth

Abstract

The BMD-SDS of patients with PWS decreases gradually despite GH treatment. As there are no clear recommendations about monitoring of bone health in patients with PWS, further studies are needed to improve the guidelines for screening of BMD and treatment of patients with PWS.

Keywords

National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:34162033 doi:10.1515/jpem-2021-0061 yuji oto nobuyuki murakami tomoyo matsubara

Access

URL:
http://www.ncbi.nlm.nih.gov/pubmed/34162033

Citation

ID: 274659
Ref Key: y2021journalgrowth
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
274659
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store